Medipan GmbH - Startseite

Speech 26-27 March 2013 of Prof. Dr. Dirk Roggenbuck at symposium "Viral immunology: From Diagnosis to treatment"  in the King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia

Symposium "Viral Immunology: From Diagnosis to treatment", March 26-27, 2013, at King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia, where our general manager, Professor Dr. Dir Roggenbuck, was invited as an speaker. His speech about Autoimmunity and Viral immunology "Exposome, infektome, and the link to autoimmunity started with the words: What was first? The chicken or the egg? The link between several infectious agents was discussed as triggers of autoimmune clinical entities. Many questions today has no answer, but interest in several diseases is growing. If you are interested in more information, please, don´t hesistate to contact our medical-scientific department (Mrs. Christina Fritz, PhD, This e-mail address is being protected from spambots. You need JavaScript enabled to view it ).

DSC08710  DSC08730

 

Dot Diver - system for automated analysis of immunodots

We are proud to present our new Dot Diver. Dot Diver is a system for automated analysis with scanner and Dr. Dot Software. The system has many benefits:

  • No reagent handling
  • Low maintenance -> No pumps 
  • Easy to use -> step by step
  • Error reduction by barcode verification
  • Time saving by short incubation times
  • Flexible -> combination of different strips

 

You need more information or you have questions? Don´t hesitate to contact us: Mr Fabian Fröhlich, phone: 0049-33708-441758, Mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

 

DotDiver klein

 

 

 

Read more: Dot Diver - system of automated analysis

 

Congratulations to our partner Medipan!

The flagship product of our partner Medipan, AKLIDES, was placed among the top 20 products within the framework of the Innovation Award in March, in the IT category E-HEALTH. The AKLIDES Nuk won the title “Best of 2012” from the Initiative Mittelstand. AKLIDES Nuk was chosen from a total of 2500 applications by a jury of over 100 people, who determined the winner with criteria of, amongst others, innovation, value and suitability for small and medium sized enterprises. This award says a lot about the quality and potential of the AKLIDES Nuk, and suggests a bright future in this area!